Mutations affecting KRAS represent an early event in PC carcinogenesis, as they are found also in precursor lesions with low-grade dysplasia, such as PanIN and IPMN with low-grade dysplasia [31]. Here, KRAS is linked to pancreatic intraductal papillary-mucinous neoplasm.